NIH 'not done' fight­ing Mod­er­na over Covid vac­cine patents, di­rec­tor Fran­cis Collins says

The NIH is stand­ing by its as­ser­tion that three of its sci­en­tists should be list­ed in the Mod­er­na patent for the com­pa­ny’s lu­cra­tive Covid-19 vac­cine.

The spat is part of an on­go­ing feud be­tween the US gov­ern­ment and Mod­er­na that spilled in­to pub­lic view last month when one of Pres­i­dent Joe Biden’s top med­ical ad­vi­sors called out the com­pa­ny for fail­ing to de­liv­er on its promise to vac­ci­nate more low- and mid­dle-in­come coun­tries.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER